Molecular Epidemiology: New Insights into Diagnosis and Prognosis

Journal of Surgical Oncology

Volumn 85, Issue 1, 2004, Pages 4-6

  Lang, Nicholas P ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Breast cancer; Colon cancer; Glutathione S transferase P1 (GSTP1); Melanoma; Myeloma; Polymorphism; Reverse transcriptase polymerase chain reaction (RT PCR); Sentinel node; Sulfotransferase 1A1 (SULT1A1); Thalidomide; Tumor necrosis factor alpha (TNF alpha)

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; EOSIN; GLUTATHIONE TRANSFERASE; HEMATOXYLIN; IMATINIB; MELANOMA ASSOCIATED ANTIBODY; MESSENGER RNA; PLATINUM DERIVATIVE; SULFOTRANSFERASE; TAMOXIFEN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TYROSINASE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ALLELE; B LYMPHOCYTE; BONE MARROW; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURVIVAL; CATALYSIS; COLORECTAL CANCER; CORRELATION ANALYSIS; DETOXIFICATION; DNA EXTRACTION; EDITORIAL; GENE EXPRESSION; GENOTYPE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE BIOPSY; MELANOMA; METASTASIS; MYELOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE; STAINING; THERMOSTABILITY;

ALLELES; ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; COLONIC NEOPLASMS; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENE EXPRESSION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MELANOMA; ORGANOPLATINUM COMPOUNDS; POLYMORPHISM, GENETIC; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SULFOTRANSFERASES; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347417023     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20007     Document Type: Editorial

References (8)

1. Blaheta HJ, Schittek B, Breuninger H, et al.: Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822-828.
2. Blaheta HJ, Paul T, Sotlar K, et al.: Detection of melanoma cells in sentinel lymph nodes, bone marrow, and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: Association with Breslow's tumour thickness. Br J Dermatol 2001;145:195-202.
3. Neben K, Mytilineos J, Moehler TM, et al.: Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 2002;100:2263-2265.
4. Zheng W, Xie D, Cerhan JR, et al.: Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:89-94.
5. Seth P, Lunetta KL, Bell DW, et al.: Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 2000;60:6859-6863.
6. Nowell S, Sweeney C, Winters M, et al.: Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst 2002;94:1635-1640.
7. Stoehlmacher J, Park DJ, Zhang W, et al.: Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 2002;94:936-942.
8. Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.